Cargando…

Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses

BACKGROUND: Cancer cachexia increases morbidity and mortality, and blocking of activin receptor ligands has improved survival in experimental cancer. However, the underlying mechanisms have not yet been fully uncovered. METHODS: The effects of blocking activin receptor type 2 (ACVR2) ligands on both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nissinen, Tuuli A., Hentilä, Jaakko, Penna, Fabio, Lampinen, Anita, Lautaoja, Juulia H., Fachada, Vasco, Holopainen, Tanja, Ritvos, Olli, Kivelä, Riikka, Hulmi, Juha J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989872/ https://www.ncbi.nlm.nih.gov/pubmed/29722201 http://dx.doi.org/10.1002/jcsm.12310

Ejemplares similares

Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle
por: Hulmi, Juha J., et al.
Publicado: (2017)

Blocking Activin Receptor Ligands Is Not Sufficient to Rescue Cancer-Associated Gut Microbiota—A Role for Gut Microbial Flagellin in Colorectal Cancer and Cachexia?
por: Pekkala, Satu, et al.
Publicado: (2019)

Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver
por: Hentilä, Jaakko, et al.
Publicado: (2019)

Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020)

Differentiation of Murine C2C12 Myoblasts Strongly Reduces the Effects of Myostatin on Intracellular Signaling
por: Lautaoja, Juulia H., et al.
Publicado: (2020)

Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes
por: Nissinen, T. A., et al.
Publicado: (2016)

Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury
por: Magga, Johanna, et al.
Publicado: (2019)

Branched-Chain Amino Acid Deprivation Decreases Lipid Oxidation and Lipogenesis in C2C12 Myotubes
por: Karvinen, Sira, et al.
Publicado: (2022)

Effects of Long-Term Physical Activity and BCAA Availability on the Subcellular Associations between Intramyocellular Lipids, Perilipins and PGC-1α
por: Fachada, Vasco, et al.
Publicado: (2023)

Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
por: Hulmi, Juha J., et al.
Publicado: (2021)

NAD(+) repletion with niacin counteracts cancer cachexia
por: Beltrà, Marc, et al.
Publicado: (2023)

ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)

Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
por: Puolakkainen, Tero, et al.
Publicado: (2017)

mTOR and Tumor Cachexia
por: Duval, Adrian P., et al.
Publicado: (2018)

Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle
por: Rinnankoski-Tuikka, Rita, et al.
Publicado: (2012)

Upregulation of activin-B and follistatin in pulmonary fibrosis – a translational study using human biopsies and a specific inhibitor in mouse fibrosis models
por: Myllärniemi, Marjukka, et al.
Publicado: (2014)

Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
por: Olsen, Oddrun Elise, et al.
Publicado: (2015)

ACVR1 Function in Health and Disease
por: Valer, José Antonio, et al.
Publicado: (2019)

Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes)
por: Trumpp, Michael, et al.
Publicado: (2023)

Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
por: Aykul, Senem, et al.
Publicado: (2022)

Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling
por: Chen, Xiangzheng, et al.
Publicado: (2016)

The effect of ACVR1B/TGFBR1/ACVR1C signaling inhibition on oocyte and granulosa cell development during in vitro growth culture
por: AKIMOTO, Yuki, et al.
Publicado: (2023)

Amino Acids in Cancer and Cachexia: An Integrated View
por: Ragni, Maurizio, et al.
Publicado: (2022)

ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children
por: Ho, Assunta CH, et al.
Publicado: (2011)

Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
por: Zhang, Wan-li, et al.
Publicado: (2019)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
por: Taylor, Kathryn R, et al.
Publicado: (2014)

Genomic Context and Mechanisms of the ACVR1 Mutation in Fibrodysplasia Ossificans Progressiva
por: Ravazzolo, Roberto, et al.
Publicado: (2021)

Severe Ocular Cowpox in a Human, Finland
por: Kinnunen, Paula M., et al.
Publicado: (2015)

Comparative analysis of silencing expression of myostatin (MSTN) and its two receptors (ACVR2A and ACVR2B) genes affecting growth traits in knock down chicken
por: Bhattacharya, T. K., et al.
Publicado: (2019)

Dietary Intake, Serum Hormone Concentrations, Amenorrhea and Bone Mineral Density of Physique Athletes and Active Gym Enthusiasts
por: Mursu, Jaakko, et al.
Publicado: (2023)

Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
por: Beltrà, Marc, et al.
Publicado: (2021)

The Skeletal Muscle as an Active Player Against Cancer Cachexia
por: Penna, Fabio, et al.
Publicado: (2019)

ACVR1 Gene Mutation in Sporadic Korean Patients with Fibrodysplasia Ossificans Progressiva
por: Lee, Dong Yeon, et al.
Publicado: (2009)

MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
por: Wang, Yongxia, et al.
Publicado: (2018)

ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma
por: Asnaghi, Laura, et al.
Publicado: (2018)

Does the expression of the ACVR2A gene affect the development of colorectal cancer?
por: Wodziński, Damian, et al.
Publicado: (2019)

Non-additive effects of ACVR2A in preeclampsia in a Philippine population
por: Amosco, Melissa D., et al.
Publicado: (2019)

Activation of AcvR1-Mediated Signaling Results in Semilunar Valve Defects
por: Syed, Shabber, et al.
Publicado: (2022)

Association of STarT Back Tool and the short form of the Örebro Musculoskeletal Pain Screening Questionnaire with multidimensional risk factors
por: Simula, Anna Sofia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_70o97d4oo8nnodifkd8hh6orhg